Results 21 to 30 of about 87,030 (164)

Pharmacologic approaches against advanced glycation end products (ages) in diabetic cardiovascular disease [PDF]

open access: yes, 2015
Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological complications in diabetic and non-diabetic patients.
Avtaar Singh, Sanjeet Singh   +6 more
core   +2 more sources

Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332. [PDF]

open access: yes, 2018
The role of high-density lipoprotein (HDL) function and advanced glycation end products (AGEs) in HIV-related atherosclerotic cardiovascular disease (CVD) is unclear.
Aberg, Judith A   +5 more
core   +1 more source

Skin advanced glycation end-products evaluation in infants according to the type of feeding and mother’s smoking habits

open access: yesSAGE Open Medicine, 2016
Objectives: This study was conducted to assess whether formula-fed infants had increased skin advanced glycation end-products compared with breastfed ones.
Giovanni Federico   +3 more
doaj   +1 more source

Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study [PDF]

open access: yes, 2005
We investigated the associations of pulse pressure (a measure of arterial stiffness) with the early glycation products hemoglobin A1c (HbA1c) and Amadori albumin and the advanced glycation end products pentosidine, Nepsilon-(carboxymethyl)lysine and ...
Bootsma, A.H.   +5 more
core   +4 more sources

Advanced glycation end products as a biomarker for incisional hernia [PDF]

open access: yes, 2017
Background: Incisional hernia is one of the most frequent complications after abdominal surgery, with incidences up to 30%. A reliable biomarker for the prediction of this complication is lacking. Advanced glycosylation end products (AGEs), also known as
Cabezas, M.C.   +7 more
core   +4 more sources

Methylglyoxal-dependent glycative stress and deregulation of SIRT1 functional network in the ovary of PCOS mice [PDF]

open access: yes, 2020
Advanced glycation end-products (AGEs) are involved in the pathogenesis and consequences of polycystic ovary syndrome (PCOS), a complex metabolic disorder associated with female infertility.
Amicarelli, F   +10 more
core   +1 more source

Leukocytes in type 1 diabetes mellitus: the changes they undergo and induce

open access: yesБіологічні студії, 2022
As leukocytes represent cellular and humoral immunity at the same time, they are a vital part of every immune process. This also stands for autoimmune processes and disorders, such as diabetes, specifically type 1 diabetes mellitus.
О. М. Kuchurka   +4 more
doaj   +1 more source

The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy [PDF]

open access: yes, 2013
The discovery of increased formation of methylglyoxal (MG) by cell metabolism in high glucose concentration in vitro suggested possible relevance to diabetes and diabetes complications (1,2).
Rabbani, Naila, Thornalley, Paul J.
core   +1 more source

Adverse effects of advanced glycation end products on embryonal development [PDF]

open access: yes, 2008
We studied the effects of advanced glycation end products (AGEs), which are known to accumulate in patients with diabetes, autoimmune diseases, or those who smoke, on embryonal development.
Hao, Lin   +6 more
core   +1 more source

Advanced Glycation End-Products in Skeletal Muscle Aging

open access: yesBioengineering, 2021
Advanced age causes skeletal muscle to undergo deleterious changes including muscle atrophy, fast-to-slow muscle fiber transition, and an increase in collagenous material that culminates in the age-dependent muscle wasting disease known as sarcopenia ...
Lucas C. Olson   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy